Desitin Arzneimittel GmbH
Headquarters country
Germany
Registry sponsor category
Industry
- Other names
- Desitin Arzneimittel GmbH
- Company name
- Desitin Arzneimittel GmbH
- Organisation type
- Industry
- Registered legal name
- Desitin Arzneimittel GmbH
- Registry sponsor category
- Industry
- Website
- http://www.desitin.de/desitin-portal/
- Legal Entity Identifier (LEI)
- 529900MUFUE31BMNG640
- Wikidata ID
- Q833296
Related records
Trials (13)
- Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.
- Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets
- Bioequivalence Study of Levetiracetam 1500 mg Coated Granules in Healthy, Male Subjects
- Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
- ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients
- EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
- Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists
- Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
- PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy
- SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease
- SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)
- Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions
- Valproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening